ATXN7L2

Model summary

A nuclear scaffold that organizes transcription-coupled chromatin-modifying assemblies to regulate RNA polymerase II–dependent gene expression. Its internal SCA7 hallmark and extended Ataxin-7–related core drive multivalent protein binding that stabilizes large nuclear complexes controlling chromatin state and transcriptional output. The protein predominantly resides in the nucleoplasm but likely cycles through cytosolic and microtubule-associated states that facilitate assembly and transport of the nuclear machinery it supports.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The polypeptide contains IPR013243 (SCA7 domain, residues 226–297) embedded within a broader IPR052237 (Ataxin-7-related family, residues 172–717). This arrangement—an internal SCA7 hallmark module nested inside a long Ataxin-7–related scaffold—defines a non-enzymatic, interaction-centric protein. The SCA7 domain is characteristic of nuclear scaffolds that assemble transcriptional and chromatin-modifying complexes rather than catalyzing chemistry. The extended family signature covering the central-to-C-terminal region implies a multivalent binding platform that stabilizes large nuclear assemblies. This architecture causally supports a molecular function centered on GO:0005515 protein binding.

2. 02

   From this binding-centric core, I infer the biological role by considering what complexes such scaffolds typically organize.

   Ataxin-7–related proteins are known to couple transcription with histone-modifying machinery. A scaffold that recruits and stabilizes chromatin-modifying modules naturally modulates RNA polymerase II–driven gene expression. This mechanistic linkage—assembly of transcription-coupled chromatin complexes—places the protein squarely in GO:0006366 transcription by RNA polymerase II.

3. 03

   The cellular context follows from the same architecture and inferred role.

   A nuclear scaffold that coordinates transcription and chromatin remodeling is expected to concentrate in the nucleoplasm, consistent with GO:0005654 nucleoplasm and the experimentally observed nuclear localization. Nonetheless, large transcriptional and RNA-processing assemblies often exchange with cytosolic pools and cytoskeletal transport systems. The presence of GO:0005829 cytosol and GO:0015630 microtubule cytoskeleton suggests a shuttling or transport-competent state: assembly and trafficking of nuclear complexes can transiently engage cytosolic and microtubule-associated machinery before nucleoplasmic incorporation. Thus, the dominant steady-state localization is nuclear/nucleoplasmic, with regulated cytosolic and microtubule-linked transit.

4. 04

   Mechanistically, the SCA7 domain and Ataxin-7–related scaffold together create a hub that recruits histone-modifying modules and transcriptional regulators.

   By stabilizing complexes that tune chromatin accessibility, the protein modulates polymerase II output at target loci. I hypothesize that it binds and organizes components of a histone acetylation/deacetylation ensemble and associated transcriptional cofactors. Likely partners include nucleoplasmic chromatin-modifying assemblies and their adaptors; transient associations with microtubule-associated transport factors could mediate its cytosolic pool and nuclear delivery. In sum, the domain architecture dictates a non-enzymatic nuclear scaffold whose primary function is multivalent protein binding that drives RNA polymerase II–coupled transcriptional regulation within the nucleoplasm, with auxiliary cytosolic and microtubule-linked interactions supporting assembly and trafficking.